In the CNS, it has been shown that CCR2 is expressed in microglia and is upregulated under pathological conditions such as multiple sclerosis, Alzheimer’s disease, and traumatic brain injury [30,41,42]. This evidence concerns the gene CCR2 and early-onset autosomal dominant Alzheimer disease.